20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

This study has been terminated.
(Safety event)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01568216
First received: February 27, 2012
Last updated: May 8, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 8, 2014